Date post: | 04-Apr-2018 |
Category: |
Documents |
Upload: | sidan-emozie |
View: | 217 times |
Download: | 0 times |
of 27
7/29/2019 HPS - Alaa Hassib
1/27
Hepatopulmonarysyndrome
(HPS)By Alaa Haseeb , MS.c
7/29/2019 HPS - Alaa Hassib
2/27
Definition:
HPS is a disease process with a triad of:1- Liver disease.2- Widespread intrapulmonary
vasodilatation.3- Gas exchange abnormality presentingwith increased alveolar arterial oxygen
gradient (P(A-a)O2) while breathingroom air, that results ultimately inhypoxemia.
7/29/2019 HPS - Alaa Hassib
3/27
7/29/2019 HPS - Alaa Hassib
4/27
Prevalence:
Studies on HPS report a wide range ofprevalence of the disease which can bedue to different patient groups and study
designs. Usually it is reported to bebetween 9 to 29% of patients with liverdisease.
7/29/2019 HPS - Alaa Hassib
5/27
Pathophysiology:
I) Vasodilatation:
Persistent pulmonary and systemicvasodilatation is mostly explained by the
imbalance of vasodilator and vasoconstrictoragents favoring vasodilators. This could be dueto:
a- Overproduction of the vasodilators from injured
hepatobiliary system.b- Decrease in their clearance by the liver.
c- Production of a vasoconstrictor inhibitor.
7/29/2019 HPS - Alaa Hassib
6/27
d- Normal sensitivity of the pulmonary vessels tovasoconstrictors in response to hypoxemia isblunted in HPS.
- Numerous vasodilators are suspected but nitricoxide ( NO) is the most appreciated one. Othermediators include vaso-active intestinal peptide(VIP), calcitonin related peptide, glucagon,substance P and platelet activating factor.
7/29/2019 HPS - Alaa Hassib
7/27
II) Hypoxemia:
- The main pathophysiologic event underlyinghypoxemia is widespread pulmonary precapillary
and capillary vasodilatation. Pulmonary capillarydiameter is normally about 8-15 micrometer(m) and this could rise up to 500 m in HPS.
- In addition, there is distinct arterio-venous (AV)malformations and direct AV communications.
- Pleural spider angiomas may also form.
7/29/2019 HPS - Alaa Hassib
8/27
These changes lead to the following:
a- Ventilation perfusion ( V/Q) mismatch:
- Results from widespread pulmonary
vasodilatation and decreased V/Q ratioin alveolar-capillary units leading to lowpressure of oxygen in arterial blood ( PaO2) andlow oxygen (O2) content of the blood leaving
these units. This hypoxemia is correctable bybreathing 100% oxygen.
7/29/2019 HPS - Alaa Hassib
9/27
b- Right to left shunting of the blood:
This results from direct arterio-venouscommunications that have no contact withbreathed air. If numerous, they can giverise to severe hypoxemia unresponsive tobreathing 100% oxygen.
7/29/2019 HPS - Alaa Hassib
10/27
c Diffusion impairment:
Excessive vasodilatation causes O2molecules not to reach the center of
dilated capillaries readily. Increasedcardiac out put and decreased transitiontime of blood through pulmonary vascularbed on the other hand impairs diffusion,this is called diffusion-perfusion defectoralveolar capillary oxygen disequilibrium.
7/29/2019 HPS - Alaa Hassib
11/27
d- Response to breathing 100% O2 :
- In response to breathing 100% oxygen if PaO2rose to levels 600mmHg, shunting of blood is
unlikely.- If it failed to exceed 500 mmHg, shunt can't beruled out.
- If it didn't rise to levels above 150-200mmHg,
shunt is most probably the main mechanism ofhypoxemia.
7/29/2019 HPS - Alaa Hassib
12/27
Clinical Manifestations:
- More than 80% of patients present withsymptoms and signs of liver disease.
- In less than 20%, the presenting
symptoms and signs are related to lungdisease. These include dyspnea, cyanosis,clubbing, platypnea and orthodeoxia.
- There is controversy on a correlationbetween the severity of liver disease andHPS.
7/29/2019 HPS - Alaa Hassib
13/27
Some studies have shown that the severerthe liver disease the severer the HPS, butothers have failed to show so.
- Mortality is high among HPS patients andis reported to be around 40% within 2-3years after presentation. Curious enough ,the causes of mortality are mostcommonly non respiratory (e.g., GIbleeding, sepsis, renal failure).
7/29/2019 HPS - Alaa Hassib
14/27
DIAGNOSIS
Diagnostic criteria for HPS are
1) Liver disease, and
2) Gas exchange abnormality manifested byhypoxemia (PaO2< 70 mmHg) and/orP(A-a)O2>20mmHg due to widespreadintrapulmonary vasodilatation, inthe absence of any primarycardiopulmonary disease.
7/29/2019 HPS - Alaa Hassib
15/27
Diagnostic Procedures:
a) Arterial blood gas analysis:
Performed in the supine and sitting
positions.
b) Chest X-rayand chest CT:
Are normal or show non-specific minorreticulonodular changes in the base of
the lungs and /or dilatation of theperipheral pulmonary vasculature.
7/29/2019 HPS - Alaa Hassib
16/27
c) Pulmonary function tests:
commonly show decreased diffusion ability of thelungs pointing to intrapulmonary vasodilatation.
d) Two dimensional contrast enhancedechocardiography (CEEC):
Is the method of choice for diagnosingintrapulmonary vasodilatation and is the mostsensitive procedure designed for this purpose.
7/29/2019 HPS - Alaa Hassib
17/27
CEEC , however, lacks specificity in that inchronic liver disease the prevalence ofpulmonary vasodilatation is about 20% by
this method despite normal gas exchangestatus. Contrast enhanced trans-esophageal echocardiography is more
sensitive than trans-thoracicechocardiography, and correlates morewith gas exchange abnormality.
7/29/2019 HPS - Alaa Hassib
18/27
e) Macro aggregated albuminscanning:
Technetium 99m- labeled macroaggregated
albumin is used. The estimated sensitivityof this method for diagnosingintrapulmonary vasodilatation is about
84% and its specificity is 100%. Inaddition, shunt fraction can be calculatedby this procedure.
7/29/2019 HPS - Alaa Hassib
19/27
f) Pulmonary angiography:
Two different angiographic patterns in HPS:
Type I:more common. There are minimalchanges with diffuse spider like branchesto more advanced changes with a blotchy,spongy appearance ( the type thatresponds to breathing 100% oxygen).
7/29/2019 HPS - Alaa Hassib
20/27
Type II: less common. There are vascularlesions as vascular dilatations representing
A-V communications ( the type that
responds poorly to breathing oxygen andliver transplantation is not as suitable asfor type I vascular lesions).
g) Pulmonary artery catheterization:
Is not used commonly for diagnosing HPS.
7/29/2019 HPS - Alaa Hassib
21/27
Treatment:
I) Medical therapy:
There are currently no medications proved tohave persistent, adequate or acceptable effect
on HPS. The following are tried:a- Almitrin bimesylate:is a stimulator of arterial
chemoreceptors ( used in COPD).
b- Indomethacin:To cause inhibition of prostaglandin production
which has a putative role of vasodilatation.
7/29/2019 HPS - Alaa Hassib
22/27
c- Methylene blue:
Is a potent inhibitor of NO and itsintracellular mediator, gunaylate cyclase
and is potentially effective for treatment ofHPS although transiently. It might be usedin the post-operative period of livertransplantation in cases with transienthypoxemia, however its routine and longterm use is not recommended yet.
7/29/2019 HPS - Alaa Hassib
23/27
II) Interventions other than livertransplantation:
a- Embolotherapy:
It is recommended that pulmonary angiographybe done for HPS patients who respond poorly tobreathing 100% oxygen i.e., PaO2
7/29/2019 HPS - Alaa Hassib
24/27
b- Portal decompression wtihtransjugular intrahepatic
portosystemic shunt (TIPS):
There is controversy regarding thebeneficial effects of this technique on HPS.Some studies confirmed the improvementof hypoxemia and others ruled out anyusefulness of TIPS. More researches areneeded undoubtfully.
7/29/2019 HPS - Alaa Hassib
25/27
III) Orthotopic Liver transplantation(OLT):
Previously, hypoxemia was considered as
an absolute contraindication for OLT.Today the trend is to give a chance to thisgroup of patients with the logic that HPSis a progressive and fatal disease andthere isn't an effective therapy whichcould improve oxygenation significantly.
7/29/2019 HPS - Alaa Hassib
26/27
The rate of improvement of HPS patientswith type I vascular lesions undergoingOLT is about 80% , but is much less in
those with type II lesions.
7/29/2019 HPS - Alaa Hassib
27/27
Thank you
Alaa Haseeb , MS.c